← FDA Drug Approvals (Drugs@FDA)

ANDA220525

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LIMITED · Approved 2026-01-28

Drug application

FDA Application #

ANDA220525

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

HETERO LABS LIMITED

First approval

2026-01-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown